CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
688217 Shanghai Rightongene Biotechnology
- 21.86
- +0.81+3.85%
Market Closed Apr 30 15:00 CST
1.22BMarket Cap-94.22P/E (TTM)
22.08High20.91Low7.93KlotVolume21.10Open21.05Pre Close17.19MTurnover1.42%Turnover RatioLossP/E (Static)55.86MShares27.8852wk High1.34P/B1.22BFloat Cap12.3852wk Low25.26Limit Up55.86MShs Float133.49Historical High16.84Limit Down5.56%Amplitude12.38Historical Low0.18Dividend TTM21.68Avg Price3.55KlotAsk0.82%Div YieldTTM100Lot Size4.15KlotBid
Shanghai Rightongene Biotechnology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -14.72%54.74M | -6.16%242.31M | -4.62%189.63M | 5.66%134.79M | 12.84%64.19M | -39.14%258.21M | -27.01%198.82M | -26.14%127.57M | 17.84%56.88M | 45.83%424.3M |
| Operating revenue | -14.72%54.74M | -6.16%242.31M | -4.62%189.63M | 5.66%134.79M | 12.84%64.19M | -39.14%258.21M | -27.01%198.82M | -26.14%127.57M | 17.84%56.88M | 45.83%424.3M |
| Total operating cost | -13.84%55.63M | -2.87%250.96M | 2.32%192.93M | 8.02%129.76M | 6.33%64.57M | -22.95%258.37M | -15.88%188.55M | -17.45%120.13M | 8.99%60.72M | 27.73%335.34M |
| Operating cost | 10.63%15.87M | -10.78%61.72M | -8.61%45.36M | -5.09%33.55M | -26.39%14.35M | -58.41%69.17M | -53.49%49.63M | -48.23%35.34M | 57.56%19.49M | 112.58%166.32M |
| Operating tax surcharges | 30.98%744.35K | 3.43%2.28M | 11.51%1.74M | 25.05%1.2M | 22.38%568.29K | 94.13%2.21M | 86.91%1.56M | 73.83%960.81K | 58.04%464.36K | 45.28%1.14M |
| Operating expense | -37.44%13.06M | -6.51%72.9M | 10.47%59.34M | 12.77%38.56M | 31.52%20.88M | 9.25%77.98M | 6.91%53.72M | 2.08%34.19M | -0.80%15.88M | -5.43%71.38M |
| Administration expense | 12.83%14.78M | 26.79%54.42M | 10.55%40.73M | 13.61%23.69M | 28.88%13.1M | 11.83%42.92M | 49.86%36.85M | 30.27%20.85M | 38.07%10.16M | -3.65%38.38M |
| Financial expense | 126.18%189.12K | 23.49%-2.84M | 69.24%-1.1M | 43.73%-1.43M | -346.59%-722.3K | 41.17%-3.71M | 46.73%-3.57M | 22.04%-2.54M | 209.37%292.92K | -1,327.48%-6.31M |
| -Interest expense (Financial expense) | ---- | 6.78%884.67K | ---- | 64.74%482.36K | ---- | 50.68%828.48K | ---- | 305.47%292.79K | ---- | 11.79%549.81K |
| -Interest Income (Financial expense) | ---- | 16.76%-3.17M | ---- | -65.89%-1.73M | ---- | -69.47%-3.81M | ---- | -90.62%-1.04M | ---- | 13.84%-2.25M |
| Research and development | -32.99%10.99M | -10.50%62.47M | -6.98%46.85M | 9.17%34.2M | 13.59%16.4M | 8.34%69.8M | 3.91%50.37M | 2.81%31.33M | -27.65%14.44M | -6.14%64.43M |
| Credit Impairment Loss | 104.07%115.96K | -24.03%-6.84M | -229.03%-5.52M | -2,893.60%-6.19M | -900.06%-2.85M | 43.28%-5.52M | 63.40%-1.68M | 72.27%-206.64K | 134.14%356.38K | -815.26%-9.73M |
| Asset Impairment Loss | -37,534.21%-120.85K | -100.06%-17.77M | -16.96%-654.43K | -17.33%-689.12K | -99.44%322.84 | 37.71%-8.88M | -346.00%-559.54K | -561.44%-587.34K | -22.47%57.22K | -2,330.97%-14.26M |
| Other net revenue | ||||||||||
| Fair value change income | 121.55%54.99K | 163.79%872.96K | -163.79%-233.42K | -680.21%-567.34K | -39.09%-255.22K | -45.69%330.93K | -55.31%365.9K | 52.84%-72.72K | -162.28%-183.49K | -70.83%609.31K |
| Invest income | 21.00%495.02K | -39.62%1.62M | -3.76%1.78M | -1.08%1.51M | -33.80%409.12K | 7.74%2.68M | 0.04%1.85M | -8.39%1.52M | -27.07%618.02K | 68.92%2.49M |
| Asset deal income | -24.17%62.24K | -85.79%119.22K | -40.17%278.04K | -78.54%101.44K | 3,047.01%82.07K | 16,083.17%838.81K | 1,016.29%464.72K | 682.35%472.76K | -18.36%-2.78K | 94.91%-5.25K |
| Other revenue | 166.91%2.09M | -47.15%2.23M | 274.95%4.06M | 444.85%3.81M | 149.81%781.25K | 15.69%4.22M | -67.07%1.08M | -64.08%700.14K | -64.71%312.74K | -41.42%3.65M |
| Operating profit | 181.17%1.8M | -338.06%-28.42M | -130.37%-3.58M | -67.52%3.01M | 17.43%-2.21M | -109.05%-6.49M | -76.15%11.79M | -69.06%9.26M | 58.02%-2.68M | 96.72%71.71M |
| Add:Non operating Income | -99.98%76.18 | 25.29%241.57K | 203.40%286.2K | 7,959,493.66%276.2K | 1,748.78%330.66K | 1,082.36%192.81K | 231.51%94.33K | -99.99%3.47 | 1,010.45%17.89K | -99.73%16.31K |
| Less:Non operating expense | -74.07%15.85K | -90.52%294.25K | -97.30%69.38K | -96.99%64.72K | -97.00%61.13K | 1,157.73%3.11M | 6,293.13%2.57M | 69,213.83%2.15M | 101,814.49%2.04M | 1,308.09%246.91K |
| Total profit | 191.61%1.78M | -202.90%-28.47M | -136.12%-3.37M | -54.72%3.22M | 58.65%-1.94M | -113.15%-9.4M | -81.16%9.32M | -76.28%7.11M | 26.39%-4.7M | 68.41%71.48M |
| Less:Income tax cost | 88.13%-60.19K | 44.13%-2.57M | -180.73%-4.91M | -128.14%-2.59M | -184.70%-506.94K | -182.62%-4.6M | -130.86%-1.75M | -142.21%-1.13M | 176.39%598.5K | 135.06%5.56M |
| Net profit | 228.11%1.84M | -439.18%-25.91M | -86.02%1.55M | -29.58%5.81M | 72.88%-1.44M | -107.29%-4.8M | -74.72%11.07M | -69.79%8.25M | 5.41%-5.3M | 64.47%65.92M |
| Net profit from continuing operation | 228.11%1.84M | -439.18%-25.91M | -86.02%1.55M | -29.58%5.81M | 72.88%-1.44M | -107.29%-4.8M | -74.72%11.07M | -69.79%8.25M | 5.41%-5.3M | 64.47%65.92M |
| Less:Minority Profit | 23.19%-1.51M | 20.36%-10.14M | 46.14%-4.18M | 57.26%-3.41M | 70.10%-1.97M | -150.05%-12.74M | -208.42%-7.76M | -232.86%-7.99M | -101.44%-6.59M | 450.85%25.45M |
| Net profit of parent company owners | 529.26%3.36M | -298.78%-15.76M | -69.58%5.73M | -43.20%9.22M | -58.70%533.17K | -80.41%7.93M | -48.58%18.83M | -23.72%16.24M | 155.38%1.29M | -14.49%40.47M |
| Earning per share | ||||||||||
| Basic earning per share | 500.00%0.06 | -300.00%-0.28 | -70.59%0.1 | -41.38%0.17 | -50.00%0.01 | -80.82%0.14 | -48.48%0.34 | -23.68%0.29 | 150.00%0.02 | -23.16%0.73 |
| Diluted earning per share | 500.00%0.06 | -300.00%-0.28 | -70.59%0.1 | -41.38%0.17 | -50.00%0.01 | -80.82%0.14 | -48.48%0.34 | -23.68%0.29 | 150.00%0.02 | -23.16%0.73 |
| Other composite income | ||||||||||
| Total composite income | 228.11%1.84M | -439.18%-25.91M | -86.02%1.55M | -29.58%5.81M | 72.88%-1.44M | -107.29%-4.8M | -74.72%11.07M | -69.79%8.25M | 5.41%-5.3M | 64.47%65.92M |
| Total composite income of parent company owners | 529.26%3.36M | -298.78%-15.76M | -69.58%5.73M | -43.20%9.22M | -58.70%533.17K | -80.41%7.93M | -48.58%18.83M | -23.72%16.24M | 155.38%1.29M | -14.49%40.47M |
| Total composite income of minority owners | 23.19%-1.51M | 20.36%-10.14M | 46.14%-4.18M | 57.26%-3.41M | 70.10%-1.97M | -150.05%-12.74M | -208.42%-7.76M | -232.86%-7.99M | -101.44%-6.59M | 450.85%25.45M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.